NCT07056582 Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries
| NCT ID | NCT07056582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Nose Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 105 participants |
| Start Date | 2025-04-14 |
| Primary Completion | 2025-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 105 participants in total. It began in 2025-04-14 with a primary completion date of 2025-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
this study aims to compare the efficacy of pre-emptive nebulized ketamine versus nebulized dexmedetomidine for post operative pain relief in endoscopic nasal surgery
Eligibility Criteria
Inclusion Criteria: * patients between the ages of 20 and 60, * both sexes, * American Society of Anesthesiologists physical status I to II * BMI ≥18≤30 kg/m² Exclusion Criteria: * Patient refusal. * patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women. * patients with a history of allergies to any study drugs. * patients who had used central nervous system depressants or analgesics within the previous 24 hours. * patients with hypertension, hypotension, or bradycardia.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07056582 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Nose Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07056582 currently recruiting?
Yes, NCT07056582 is actively recruiting participants. Contact the research team at ahmedthanocloser460@gmail.com for enrollment information.
Where is the NCT07056582 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07056582 clinical trial?
NCT07056582 is sponsored by Sohag University. The trial plans to enroll 105 participants.